HB510 Summary

• Prohibits occupational licensing boards from revoking, suspending, or taking adverse action against physicians who recommend non-FDA-approved COVID-19 treatments if the physician exercised independent medical judgment and the patient provided written, informed consent.

• Requires pharmacies to fill prescriptions for non-FDA-approved drugs, biological products, or devices prescribed for COVID-19 treatment and prohibits blocking patient access based solely on lack of FDA approval.

• Requires health care facilities to provide patient-requested off-label uses of FDA-approved drugs, biological products, or devices for COVID-19 treatment.

• Provides civil causes of action with remedies including injunctive relief, reinstatement of licenses, reasonable attorney fees, and court costs for physicians, patients, or those harmed by violations.

• Grants civil liability immunity to pharmacists, licensing boards, and health care facilities that comply with the bill's provisions when administering or prescribing COVID-19 treatments.